Atlas Trials

Study of a Live rNDV Based Vaccine Against COVID-19

Clinical trial NCT04871737 · COMPLETED

Trial details

NCT number
NCT04871737
Sponsor
Laboratorio Avi-Mex, S.A. de C.V.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SARS-CoV-2 Infection
Start date
2021-05-20
Primary completion
2022-08-21
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.